Effect of zoledronate acid treatment on osseointegration and fixation of implants in autologous iliac bone grafts in ovariectomized rabbits.

Abstract:

:One main problem associated with alveolar bone augmentation in implant dentistry is resorption of grafted bone, which may be further compromised by systemic skeletal disorders such as osteoporosis. Zoledronate acid (ZOL) is the most potent bisphosphonate to treat osteoporosis and therefore it is hypothesized to be able to invert the negative effect of osteoporosis on osseointegration and fixation of dental implants in autologous bone grafts. In this study, 56 rabbits received bilateral ovariectomy (OVX) (40 rabbits) or sham operation (16 rabbits). Three months later, 8 animals from each group were sacrificed for bone mineral density (BMD) examination. Then the remaining animals underwent bilateral autologous iliac bone grafting with simultaneous implantation of titanium implants in tibiae and were divided into 5 groups (n=8): Sham, OVX, Loc-ZOL (local treatment), Sys-ZOL (systemic treatment) and Loc+Sys-ZOL (local plus systemic) group. At 3 months after implantation, all animals were sacrificed and specimens were harvested for examinations. Both BMD and histological examinations of femurs showed osteoporotic changes after ovariectomy, while systemic treatment with ZOL restored mineralized bone. Micro-CT examination demonstrated that OVX group showed significant decrease of mineralized bone and implant-bone contact when compared with sham control, whereas both systemic and local treatments of ZOL significantly increased mineralized bone and implant-bone contact in ovariectomized animals. However, the best effects were observed in Loc+Sys-ZOL group (combined use of ZOL) and most of bone indices were similar to (IBCR, p>0.05) or higher than (BV/TV, Conn.D and Tb.N) (p<0.01) those of the sham group, except Tb.Th, which was still significantly lower (p<0.01), and Tb.Sp, which was further decreased (p<0.01). The aforementioned effects were also confirmed by histomorphometric analysis of bone indices on implant-bone contact and mineralized bone. In addition, biomechanical testing further supported the beneficial effect of ZOL treatment and maximal removal torque of titanium implants was observed in Loc+Sys-ZOL group. In conclusion, our study suggests that both systemic and local treatments with ZOL can invert negative effect of osteoporosis and promote osseointegration and fixation of dental implants in autologous bone grafts under osteoporotic condition. Combined systemic and local use of ZOL exerts best effects when compared to their single use.

journal_name

Bone

journal_title

Bone

authors

Qi M,Hu J,Li J,Li J,Dong W,Feng X,Yu J

doi

10.1016/j.bone.2011.10.011

subject

Has Abstract

pub_date

2012-01-01 00:00:00

pages

119-27

issue

1

eissn

8756-3282

issn

1873-2763

pii

S8756-3282(11)01291-9

journal_volume

50

pub_type

杂志文章

相关文献

BONE文献大全
  • A theoretical analysis of the contributions of remodeling space, mineralization, and bone balance to changes in bone mineral density during alendronate treatment.

    abstract::In patients with osteoporosis, alendronate treatment causes an increase in bone mineral density (BMD) and a decrease in fracture incidence. Alendronate acts by changing the bone remodeling process. Changes in bone remodeling resulting in decreased remodeling space, increased bone balance per remodeling cycle, and incr...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(01)00613-5

    authors: Hernandez CJ,Beaupré GS,Marcus R,Carter DR

    更新日期:2001-12-01 00:00:00

  • Measurement and estimation of osteocyte mechanical strain.

    abstract::Osteocytes are the most abundant cell type in bone and are responsible for sensing mechanical strain and signaling bone (re)modeling, making them the primary mechanosensors within bone. Under aging and osteoporotic conditions, bone is known to be less responsive to loading (exercise), but it is unclear why. Perhaps, t...

    journal_title:Bone

    pub_type: 杂志文章,评审

    doi:10.1016/j.bone.2013.01.037

    authors: Stern AR,Nicolella DP

    更新日期:2013-06-01 00:00:00

  • Granulocyte-macrophage colony-stimulating factor-dependent CD11c-positive cells differentiate into active osteoclasts.

    abstract::Levels of circulating cytokines are elevated in inflammatory diseases. Previously, it was shown that interleukin (IL-)17A, in synergism with 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] and tumor necrosis factor α (TNFα), induces the release of granulocyte-macrophage colony-stimulating factor (GM-CSF) by murine osteoblasts ...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2017.01.036

    authors: Ruef N,Dolder S,Aeberli D,Seitz M,Balani D,Hofstetter W

    更新日期:2017-04-01 00:00:00

  • Parathyroid hormone therapy accelerates recovery from immobilization-induced osteopenia.

    abstract::Previous reports have shown that bone mass and architecture will partially recover by remobilization (RM) in immobilization (IM)-induced osteopenia. The aim of this study was to test whether PTH can accelerate the recovery during RM from the IM-induced osteopenia. Six-month-old Sprague-Dawley female rats were divided ...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/8756-3282(95)00295-o

    authors: Yuan ZZ,Jee WS,Ma YF,Wei W,Ijiri K

    更新日期:1995-10-01 00:00:00

  • Osteoconduction in large macroporous hydroxyapatite ceramic implants: evidence for a complementary integration and disintegration mechanism.

    abstract::Large, cylindrical implants of a porous calcium phosphate ceramic ("hydroxyapatite" starting material, HAC) were used to replace far greater than critical-sized sections of the midshaft of sheep tibiae and retrieved at 2 and 9 months; external fixation was used in the first 5 months. Excellent clinical function of the...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(99)00083-6

    authors: Boyde A,Corsi A,Quarto R,Cancedda R,Bianco P

    更新日期:1999-06-01 00:00:00

  • Atypical incomplete femoral fractures in asymptomatic patients on long term bisphosphonate therapy.

    abstract:OBJECTIVES:Progression of an incomplete atypical femoral fracture (IF) to a complete fracture in patients on long term bisphosphonate (BP) therapy can be catastrophic. We aimed to determine the frequency and imaging features of IF in asymptomatic patients on long-term BP therapy and to identify distinguishing clinical ...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2013.03.018

    authors: Allison MB,Markman L,Rosenberg Z,Vieira RL,Babb J,Tejwani N,Peck V

    更新日期:2013-07-01 00:00:00

  • Identification of material parameters based on Mohr-Coulomb failure criterion for bisphosphonate treated canine vertebral cancellous bone.

    abstract::Nanoindentation has been widely used to study bone tissue mechanical properties. The common method and equations for analyzing nanoindentation, developed by Oliver and Pharr, are based on the assumption that the material is linearly elastic. In the present study, we adjusted the constraint of linearly elastic behavior...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2008.05.023

    authors: Wang X,Allen MR,Burr DB,Lavernia EJ,Jeremić B,Fyhrie DP

    更新日期:2008-10-01 00:00:00

  • Bisphosphonates--history and experimental basis.

    abstract::This paper reviews the mechanisms of action of the bisphosphonates, a new class of recently developed drugs. The geminal bisphosphonates are characterized by a P-C-P bond and are thus analogs of pyrophosphate. They bind strongly to hydroxyapatite crystals and in vitro inhibit both crystal formation and dissolution. In...

    journal_title:Bone

    pub_type: 历史文章,杂志文章,评审

    doi:

    authors: Fleisch H

    更新日期:1987-01-01 00:00:00

  • High-resolution morphometric analysis of human osteoblastic cell adhesion on clinically relevant orthopedic alloys.

    abstract::Understanding the cellular basis of osteoblastic cell-biomaterial interaction is crucial to the analysis of the mechanism of osseointegration, a requirement of long-term orthopedic implant stability. Clinically, the amount of bone ingrowth is variable, and cellular parameters that influence ingrowth have yet to be cle...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(99)00077-0

    authors: Shah AK,Sinha RK,Hickok NJ,Tuan RS

    更新日期:1999-05-01 00:00:00

  • Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: a key mechanism in osteoporosis.

    abstract::Compelling evidences suggest that increased production of osteoclastogenic cytokines by activated T cells plays a relevant role in the bone loss induced by estrogen deficiency in the mouse. However, little information is available on the role of T cells in post-menopausal bone loss in humans. To investigate this issue...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2008.02.017

    authors: D'Amelio P,Grimaldi A,Di Bella S,Brianza SZM,Cristofaro MA,Tamone C,Giribaldi G,Ulliers D,Pescarmona GP,Isaia G

    更新日期:2008-07-01 00:00:00

  • Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-month, randomized, placebo-controlled, double-blind and 12-month open-label phases.

    abstract::This multicenter study assessed the safety and efficacy of teriparatide 20 microg/day in Japanese men and women with osteoporosis at high risk of fracture during a 12-month, randomized, double-blind, placebo-controlled treatment period followed by second and third treatment periods (to 18 and 24 months, respectively,)...

    journal_title:Bone

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.bone.2010.05.022

    authors: Miyauchi A,Matsumoto T,Sugimoto T,Tsujimoto M,Warner MR,Nakamura T

    更新日期:2010-09-01 00:00:00

  • Risk of fracture in women treated with monthly oral ibandronate or weekly bisphosphonates: the eValuation of IBandronate Efficacy (VIBE) database fracture study.

    abstract::The eValuation of IBandronate Efficacy (VIBE) head-to-head database fracture study compared fracture rates between patients treated with monthly ibandronate and weekly oral bisphosphonates (BPs). This large study included women >/=45 years old, newly prescribed monthly oral ibandronate or weekly oral alendronate or ri...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2009.01.002

    authors: Harris ST,Reginster JY,Harley C,Blumentals WA,Poston SA,Barr CE,Silverman SL

    更新日期:2009-05-01 00:00:00

  • Bone mineral density in asthmatic women on high-dose inhaled beclomethasone dipropionate.

    abstract::Inhaled corticosteroids are the cornerstone of the modern therapy for asthma. In recent years, inhaled corticosteroids have been used in higher doses than previously. This has caused concern about possible osteoporotic side-effects. We studied bone mineral densities (BMDs) in 19 non-smoking women (mean age 53 years, r...

    journal_title:Bone

    pub_type: 临床试验,杂志文章

    doi:10.1016/8756-3282(94)90309-3

    authors: Herrala J,Puolijoki H,Impivaara O,Liippo K,Tala E,Nieminen MM

    更新日期:1994-11-01 00:00:00

  • Longitudinal changes in lean mass predict pQCT measures of tibial geometry and mineralisation at 6-7 years.

    abstract:BACKGROUND:Studies in childhood suggest that both body composition and early postnatal growth are associated with bone mineral density (BMD). However, little is known of the relationships between longitudinal changes in fat (FM) and lean mass (LM) and bone development in pre-pubertal children. We therefore investigated...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2015.02.015

    authors: Moon RJ,Cole ZA,Crozier SR,Curtis EM,Davies JH,Gregson CL,Robinson SM,Dennison EM,Godfrey KM,Inskip HM,Cooper C,Harvey NC,Southampton Women's Survey Study Group.

    更新日期:2015-06-01 00:00:00

  • Hyperphosphatemia with low FGF7 and normal FGF23 and sFRP4 levels in the circulation characterizes pediatric hypophosphatasia.

    abstract::Hypophosphatasia (HPP) is the inborn-error-of-metabolism caused by loss-of-function mutation(s) of the ALPL gene that encodes the tissue-nonspecific isoenzyme of alkaline phosphatase (TNSALP). TNSALP in healthy individuals is on cell surfaces richly in bone, liver, and kidney. Thus, TNSALP natural substrates accumulat...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2020.115300

    authors: Whyte MP,Zhang F,Wenkert D,Mumm S,Berndt TJ,Kumar R

    更新日期:2020-05-01 00:00:00

  • Cardiovascular and skeletal safety of zoledronic acid in osteoporosis observational, matched cohort study using Danish and Swedish health registries.

    abstract:BACKGROUND:This observational safety study used national registers to compare the real world cardiovascular and skeletal safety of zoledronic acid (ZA) against oral bisphosphonates (oBP) and untreated population controls. METHODS:Propensity score matched cohort study in Sweden and Denmark. RESULTS:Matched cohort 1 in...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2020.115296

    authors: Rubin KH,Möller S,Choudhury A,Zorina O,Kalsekar S,Eriksen EF,Andersen M,Abrahamsen B

    更新日期:2020-05-01 00:00:00

  • Ginsenoside Rh2 inhibits osteoclastogenesis through down-regulation of NF-κB, NFATc1 and c-Fos.

    abstract::Ginsenoside Rh2 is one of the most active components of red ginseng, controlling cancer and other metabolic diseases including osteoclast differentiation. However, the molecular mechanism underlying the inhibition of osteoclast differentiation by ginsenoside Rh2 remains poorly understood. In the present study, it was ...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2012.03.022

    authors: He L,Lee J,Jang JH,Lee SH,Nan MH,Oh BC,Lee SG,Kim HH,Soung NK,Ahn JS,Kim BY

    更新日期:2012-06-01 00:00:00

  • Peroxisome proliferator activated receptor-gamma (PPARgamma) represses thyroid hormone signaling in growth plate chondrocytes.

    abstract::Peroxisome proliferator activated receptors (PPARs) are DNA-binding nuclear hormone receptors that are upregulated in response to high fat diets. PPARs are structurally related to the type II nuclear receptors, including the thyroid hormone receptors (TRs). To investigate if PPARs modulate TR-mediated terminal differe...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2005.04.031

    authors: Wang L,Shao YY,Ballock RT

    更新日期:2005-09-01 00:00:00

  • Estrogen receptor gene polymorphism and bone mineral density at the lumbar spine of pre- and postmenopausal women.

    abstract::In order to analyze the role of the estrogen receptor (ER) gene allelic polymorphisms on bone mineral density (BMD), 173 pre- and postmenopausal women were divided into four groups according to their menstrual status (group A: premenopausal women; group B: late premenopausal women; group C: postmenopausal women who ha...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(97)00178-6

    authors: Mizunuma H,Hosoi T,Okano H,Soda M,Tokizawa T,Kagami I,Miyamoto S,Ibuki Y,Inoue S,Shiraki M,Ouchi Y

    更新日期:1997-11-01 00:00:00

  • Spatial mapping of mineralization with manganese-enhanced magnetic resonance imaging.

    abstract::Paramagnetic manganese can be employed as a calcium surrogate to sensitize the magnetic resonance imaging (MRI) technique to the processing of calcium during the bone formation process. At low doses, after just 48h of exposure, osteoblasts take up sufficient quantities of manganese to cause marked reductions in the wa...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2011.02.014

    authors: Chesnick IE,Centeno JA,Todorov TI,Koenig AE,Potter K

    更新日期:2011-05-01 00:00:00

  • Biological and clinical assessment of a new bisphosphonate, (chloro-4 phenyl) thiomethylene bisphosphonate, in the treatment of Paget's disease of bone.

    abstract::Several Biophosphonates have been used as therapeutic agents for Paget's bone disease. (Chloro-4 phenyl)thiomethylene-bisphosphonate (CIPsMBP) has recently been shown to have significant antiosteoclastic activity while an affect of CIPsMBP on mineralization was only observed at high doses. We tested this drug for 6 mo...

    journal_title:Bone

    pub_type: 临床试验,杂志文章

    doi:10.1016/8756-3282(88)90115-9

    authors: Reginster JY,Jeugmans-Huynen AM,Albert A,Denis D,Deroisy R,Lecart MP,Fontaine MA,Collette J,Franchimont P

    更新日期:1988-01-01 00:00:00

  • Mechanistic and therapeutic insights gained from studying rare skeletal diseases.

    abstract::Rare bone diseases account for 5% of all birth defects and can cause significant morbidity throughout patients' lives. Significant progress is being made to elucidate the pathophysiological mechanisms underlying these diseases. This paper summarizes presentation highlights of a workshop on Rare Skeletal Diseases conve...

    journal_title:Bone

    pub_type: 杂志文章,评审

    doi:10.1016/j.bone.2015.03.016

    authors: Tosi LL,Warman ML

    更新日期:2015-07-01 00:00:00

  • Bone mineral density in Anorexia Nervosa versus Avoidant Restrictive Food Intake Disorder.

    abstract:BACKGROUND:Avoidant Restrictive Food Intake Disorder (ARFID) and Anorexia Nervosa (AN) cause significant underweight in children and young people (CYP). The association of low bone mineral density (BMD) and underweight CYP in AN is well established, but less is known about BMD in ARFID. METHODS:Retrospective case-note...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2020.115307

    authors: Alberts Z,Fewtrell M,Nicholls DE,Biassoni L,Easty M,Hudson LD

    更新日期:2020-05-01 00:00:00

  • Effects of cod bone gelatin on bone metabolism and bone microarchitecture in ovariectomized rats.

    abstract::Several animal studies have showed that gelatin may be effective for minimizing bone loss in OVX rats with established osteopenia. To gain insight into how cod bone gelatin administration affects bone loss after ovariectomy, studies were carried out focusing on bone quality and the molecular mechanisms. Eighty-four fe...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2008.12.005

    authors: Han X,Xu Y,Wang J,Pei X,Yang R,Li N,Li Y

    更新日期:2009-05-01 00:00:00

  • Sclerostin levels and bone turnover markers in adolescents with anorexia nervosa and healthy adolescent girls.

    abstract::Sclerostin, product of the SOST gene, is an important determinant of bone formation and resorption. Adolescents with anorexia nervosa (AN) have low bone density and decreased levels of bone turnover markers. However, sclerostin has not been examined in AN as a potential mediator of impaired bone metabolism. Our study ...

    journal_title:Bone

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.bone.2012.06.006

    authors: Faje AT,Fazeli PK,Katzman DK,Miller KK,Breggia A,Rosen CJ,Mendes N,Klibanski A,Misra M

    更新日期:2012-09-01 00:00:00

  • Expression of bone microsomal casein kinase II, bone sialoprotein, and osteopontin during the repair of calvarial defects.

    abstract::The temporal expression of bone microsomal casein kinase II, osteopontin, bone sialoprotein, alkaline phosphatase, and the accumulation of a solid calcium-inorganic orthophosphate mineral phase, have been charted from day 2 to day 21 during the repair of calvarial defects in rats induced by the implantation of decalci...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(98)00057-x

    authors: Wang J,Glimcher MJ,Mah J,Zhou HY,Salih E

    更新日期:1998-06-01 00:00:00

  • Mouse polycomb group gene Cbx2 promotes osteoblastic but suppresses adipogenic differentiation in postnatal long bones.

    abstract::A set of key developmental genes is essential for skeletal growth from multipotent progenitor cells at weaning. Polycomb group proteins, which regulate such genes contributes to the cell lineage commitment and subsequent differentiation via epigenetic chromatin modification and remodeling. However, it is unclear which...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2018.10.021

    authors: Katoh-Fukui Y,Baba T,Sato T,Otake H,Nagakui-Noguchi Y,Shindo M,Suyama M,Ohkawa Y,Tsumura H,Morohashi KI,Fukami M

    更新日期:2019-03-01 00:00:00

  • Salmon calcitonin treatment by nasal spray in primary hyperparathyroidism.

    abstract::The hypocalcemic and hypophosphatemic effect of salmon calcitonin (sCT) given by intranasal (i.n.) spray to 12 patients with histological confirmed primary hyperparathyroidism (1 degree HPT) was studied. The concentration of ionized calcium in whole blood (B-Ca++), serum phosphate (S-P), magnesium (S-Mg), plasma sCT (...

    journal_title:Bone

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/8756-3282(91)90016-c

    authors: Tørring O,Bucht E,Sjöstedt U,Sjöberg HE

    更新日期:1991-01-01 00:00:00

  • Low peak bone mineral density in healthy Lebanese subjects.

    abstract::Osteoporosis is a major public health problem in Western countries and is projected to have a similar impact in the Middle East. It has been suggested that peak bone mineral density (BMD), a major determinant of osteoporotic fractures later in life, may be lower in this part of the world compared with the Western worl...

    journal_title:Bone

    pub_type: 临床试验,杂志文章

    doi:10.1016/s8756-3282(02)00845-1

    authors: El-Hajj Fuleihan G,Baddoura R,Awada H,Salam N,Salamoun M,Rizk P

    更新日期:2002-10-01 00:00:00

  • Phenotypic characterization of Grm1crv4 mice reveals a functional role for the type 1 metabotropic glutamate receptor in bone mineralization.

    abstract::Recent increasing evidence supports a role for neuronal type signaling in bone. Specifically glutamate receptors have been found in cells responsible for bone remodeling, namely the osteoblasts and the osteoclasts. While most studies have focused on ionotropic glutamate receptors, the relevance of the metabotropic glu...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2016.10.025

    authors: Musante I,Mattinzoli D,Otescu LA,Bossi S,Ikehata M,Gentili C,Cangemi G,Gatti C,Emionite L,Messa P,Ravazzolo R,Rastaldi MP,Riccardi D,Puliti A

    更新日期:2017-01-01 00:00:00